About Amazentis
Amazentis is a company based in Lausanne (Switzerland) founded in 2007.. Amazentis has raised $8.9 million across 2 funding rounds from investors including Nestlé Health Science. Amazentis offers products and services including Mitopure Softgels, The Day Cream, Mitopure Powder, The Night Cream, and The Serum. Amazentis operates in a competitive market with competitors including DecodeAge, Biote, Timeline, Ponce De Leon Health and Nuchido, among others.
- Headquarter Lausanne, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Total Equity Funding
$8.9 M (USD)
in 2 rounds
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amazentis
Amazentis offers a comprehensive portfolio of products and services, including Mitopure Softgels, The Day Cream, Mitopure Powder, The Night Cream, and The Serum. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Dietary supplement for cellular energy and health support.
Cream that strengthens skin barrier and reduces aging signs.
Powder for daily health routine and mitochondrial benefits.
Cream for skin regeneration and resilience overnight.
Serum that lifts and firms skin with Urolithin A.
Unlock access to complete
Sales and Marketing
9 people
Leadership Team
6 people
Software Development Team
4 people
Creative and Marketing Team
3 people
Senior Team
1 people
Customer Team
1 people
Human Resources and Administration
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Amazentis
Amazentis has successfully raised a total of $8.9M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(21 Mar 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Series C - Amazentis | Valuation | Nestlé Health Science |
|
| Mar, 2018 | Amount | Series C - Amazentis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amazentis
Amazentis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Nestlé Health Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nutritional dietary supplements are provided for health and wellness needs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amazentis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Amazentis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amazentis Comparisons
Competitors of Amazentis
Amazentis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DecodeAge, Biote, Timeline, Ponce De Leon Health and Nuchido, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Online platform offering drugs for longevity and age health
|
|
| domain | founded_year | HQ Location |
Hormone replacement and pellet therapy services are offered.
|
|
| domain | founded_year | HQ Location |
Clinically-tested Urolithin A supplements and skincare are developed.
|
|
| domain | founded_year | HQ Location |
Anti-aging nutraceutical supplements are developed and tested.
|
|
| domain | founded_year | HQ Location |
Manufacturer of dietary supplements
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amazentis
Frequently Asked Questions about Amazentis
When was Amazentis founded?
Amazentis was founded in 2007 and raised its 1st funding round 11 years after it was founded.
Where is Amazentis located?
Amazentis is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Is Amazentis a funded company?
Amazentis is a funded company, having raised a total of $8.9M across 2 funding rounds to date. The company's 1st funding round was a Series C of $8.9M, raised on Mar 21, 2018.
What is the annual revenue of Amazentis?
Annual revenue of Amazentis is $403.09K as on Mar 31, 2022.
What does Amazentis do?
Amazentis is a biotechnology company based in Switzerland that is developing innovative nutritional products to combat aging and improve the quality of life. Amazentis focus is on harnessing the effects of Urolithin A on aging mitochondria - a finding that the founders reported in a landmark research article in the journal Nature Medicine where they showed that Urolithin A induces mitophagy and prolong life span in nematodes, and improves muscle function in rodents. Urolithin A is produced naturally by human gut bacteria by the conversion of ellagitannins - natural precursor compounds found in, among others, pomegranates. Once taken up by cells, Urolithin A acts by preventing the accumulation of dysfunctional mitochondria in aging cells.
Who are the top competitors of Amazentis?
What products or services does Amazentis offer?
Amazentis offers Mitopure Softgels, The Day Cream, Mitopure Powder, The Night Cream, and The Serum.
Who are Amazentis's investors?
Amazentis has 1 investor. Key investors include Nestlé Health Science.